Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | XERS | LYRA | AKBA | ||
Company | Xeris Pharmaceuticals Inc | Lyra Therapeutics Inc | Akebia Therapeutics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.9000 | 4.66 | 1.3400 | ||
High | 1.9300 | 4.71 | 1.4200 | ||
Low | 1.8400 | 3.92 | 1.3200 | ||
Last | 1.8900 | 4.03 | 1.3700 | ||
Change | +0.0300 | -0.60 | +0.0700 | ||
% Change | +1.61% | -12.96% | +5.38% | ||
Volume | 1,130,200 | 2,439,800 | 3,117,000 | ||
20-Day Average Volume | 1,285,505 | 382,010 | 3,129,295 | ||
Previous Close | 1.8600 | 4.63 | 1.3000 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 1.8330 | 5.12 | 1.3905 | ||
20-Day Raw Stochastic | 53.33% | 5.95% | 38.27% | ||
20-Day Relative Strength | 43.49% | 33.69% | 45.10% | ||
Weighted Alpha | -18.22 | +9.08 | +2.73 | ||
Today's Opinion | 40% Sell | 24% Sell | 8% Buy | ||
Previous Opinion | 40% Sell | 8% Buy | 24% Sell | ||
Last Month's Opinion | 40% Sell | 64% Buy | 64% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +8.00% since 04/26/24 | -14.62% since 04/26/24 | +2.24% since 04/26/24 | ||
Low | 1.7100 on 04/29/24 | 3.92 on 05/03/24 | 1.2150 on 05/02/24 | ||
High | 1.9300 on 05/03/24 | 5.65 on 05/01/24 | 1.4200 on 05/03/24 | ||
1-Month | |||||
%Chg | -9.13% since 04/03/24 | -26.19% since 04/03/24 | -8.05% since 04/03/24 | ||
Low | 1.6900 on 04/26/24 | 3.92 on 05/03/24 | 1.2150 on 05/02/24 | ||
High | 2.1100 on 04/04/24 | 5.77 on 04/17/24 | 1.6200 on 04/10/24 | ||
3-Month | |||||
%Chg | -22.86% since 02/02/24 | -13.89% since 02/02/24 | -16.97% since 02/02/24 | ||
Low | 1.6900 on 04/26/24 | 3.92 on 05/03/24 | 1.2150 on 05/02/24 | ||
High | 3.2600 on 02/15/24 | 6.79 on 03/27/24 | 2.4800 on 03/28/24 | ||
6-Month | |||||
%Chg | -0.53% since 11/03/23 | +29.17% since 11/03/23 | +44.99% since 11/03/23 | ||
Low | 1.4600 on 11/15/23 | 2.50 on 11/09/23 | 0.8800 on 11/13/23 | ||
High | 3.2600 on 02/15/24 | 6.79 on 03/27/24 | 2.4800 on 03/28/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 275,752 | 282,268 | 272,184 | ||
Shares Outstanding, K | 148,254 | 60,965 | 209,372 | ||
Annual Sales | 163,910,000 | 1,560,000 | 194,620,000 | ||
Annual Net Income | -62,260,000 | -62,680,000 | -51,930,000 | ||
Last Quarter Sales | 44,390,000 | 150,000 | 56,070,000 | ||
Last Quarter Net Income | -13,390,000 | -15,160,000 | -50,000 | ||
60-Month Beta | 2.37 | 0.31 | 0.94 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.10 on 03/06/24 | -0.35 on 04/30/24 | 0.00 on 03/14/24 | ||
Latest Earnings Date | 05/14/24 | 05/10/24 | 05/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |